CD44 and Miyoshi myopathy: To investigate if AR-42 treatment could affect CD44 expression in vivo, we created a xenograft MM mouse model by injecting 1 × 107 viable cells of MM.1S cell line subcutaneously into the right flank of 12 NOD-SCID mice.